Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion

Published:2018-12-01 Issue:12 Volume:136 Page:1391
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

McAllister Ian L.¹²,Smithies Lynne A.¹,Chen Fred K.¹²,Mackey David A.¹,Sanfilippo Paul G.¹³

Affiliation:

1. Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia

2. Department of Ophthalmology, Royal Perth Hospital, Perth, Western Australia, Australia

3. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, Victoria, Australia

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Reference30 articles.

1. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.;Brown;Ophthalmology,2010

2. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.;Campochiaro;Ophthalmology,2011

3. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.;Brown;Am J Ophthalmol,2013

4. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.;Heier;Ophthalmology,2012

5. Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study.;Heier;Ophthalmology,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central retinal vein occlusion;Retinal and Choroidal Vascular Diseases of the Eye;2024

2. Benefits of a Laser Chorioretinal Anastomosis Plus Ranibizumab vs Ranibizumab Alone for Central Retinal Vein Occlusion: 4-Year Results;American Journal of Ophthalmology;2023-08

3. Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF;Ophthalmology Retina;2023-04

4. Long-term outcomes for patients treated for macular oedema secondary to retinal vein occlusion: a systematic review;BMJ Open Ophthalmology;2022-06

5. Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy;BMJ Open Ophthalmology;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3